Skip to main content
. 2016 Dec 1;7(12):e2496. doi: 10.1038/cddis.2016.378

Figure 1.

Figure 1

Dnmt3a is upregulated by AP2α during the CI stage. (a) Illustration of the murine Dnmt3a promoter (−1.7 to +0.1 kb) is shown and two reported AP2α binding sites were identified in the proximal region. (b) Correlation coefficient analysis of AP2α and Dnmt3a mRNA expression profiles during the CI stage. The mRNA expressions of AP2α and Dnmt3a at different time points during the CI stage were determined by real-time PCR and normalized to glyceraldehyde-3-phosphate dehydrogenase. (c) Real-time PCR analysis of the expression of Dnmt3a in AP2α knockdown cells (si-1 and si-2) at ci48 h. The results were analyzed as means±S.D. (n=3). Statistical significance is indicated: ***P<0.001. (d) Western blotting analysis of the expression of Dnmt3a in AP2α knockdown cells at ci48 h. Cyclin-dependent kinase 4 served as the loading control. Quantification analysis of the relative protein level of Dnmt3a in AP2α knockdown cells was shown on the right panel. The results were analyzed as means±S.D. (n=3). Statistical significance is indicated: **P<0.01. (e) A luciferase reporter plasmid of the murine Dnmt3a promoter (−1.7 to +0.1 kb) and an HA-AP2α cDNA plasmid were constructed for dual-luciferase assay. Results were expressed as firefly luciferase activity normalized to renilla luciferase activity. Error bars indicate S.D. (n=3). Statistical significance is indicated: *P<0.05, **P<0.01. Gradient expression of HA-AP2α was detected by western blotting (bottom panel)